共 50 条
Langerhans Cell Histiocytosis and Langerhans Cell Sarcoma: Current Understanding and Differential Diagnosis
被引:2
作者:
Nakamine, Hirokazu
[1
]
Yamakawa, Mitsunori
[2
]
Yoshino, Tadashi
[3
]
Fukumoto, Takaya
[4
]
Enomoto, Yasunori
[5
]
Matsumura, Itaru
[6
]
机构:
[1] Japan Baptist Hosp, Dept Lab Med, Kyoto, Japan
[2] Yamagata Univ, Fac Med, Dept Pathol Diagnost, Yamagata, Japan
[3] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama, Japan
[4] Sapporo Dermatopathol Inst, Sapporo, Hokkaido, Japan
[5] Toho Univ, Ohashi Med Ctr, Dept Pathol, Tokyo, Japan
[6] Kinki Univ, Fac Med, Dept Internal Med, Div Hematol & Rheumatol, Osaka, Japan
关键词:
Langerhans cell histiocytosis;
Langerhans cell sarcoma;
BRAF mutation;
trans-differentiation;
differential diagnosis;
D O I:
暂无
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Langerhans cell (LC) histiocytosis (LCH) and LC sarcoma (LCS) are proliferative processes consisting of cells having morphologic and phenotypic features of Langerhans cells (LCs), although the latter may have lost some of these features. Because neoplastic nature of LCH as well as LCS is more likely by recent studies, a category of LC hyperplasia can be better characterized. LCH and LCS are rarely seen in daily pathology practice, but it is important to accurately characterize these lesions. For this purpose, an outline covering proliferations of LC and related cells was constructed. The scheme of this outline is based especially on evaluating borderline lesions, neoplastic trans-differentiation, and degree of similarity with the normal counterparts. In addition, the organization and update of the current classification scheme for histiocytic and dendritic-cell proliferations is presented.
引用
收藏
页码:109 / 118
页数:10
相关论文
共 50 条